What Fueled The Previous Growth In The Mesenchymal Stem Cells Market?
The mesenchymal stem cells market has seen considerable growth due to a variety of factors.
• The mesenchymal stem cells market has expanded rapidly in recent years. It will grow from $3.38 billion in 2024 to $3.82 billion in 2025, reflecting a CAGR of 13.0%.
The growth drivers include a shift in the regenerative medicine paradigm, collaborative research efforts, greater public awareness of stem cell research, and international collaboration and standardization initiatives.
How Does the Forecast Look for the Mesenchymal Stem Cells Market?
The mesenchymal stem cells market is expected to maintain its strong growth trajectory in upcoming years.
• The mesenchymal stem cells market is expected to grow to $6.14 billion by 2029, with a CAGR of 12.6%.
Growth is attributed to advancements in genetic engineering, personalized medicine, AI and data analytics integration, biomaterials science, 3D bioprinting technologies, microfluidic devices, and next-generation manufacturing. Trends include bioprinting, tissue engineering, gene editing, clinical applications, combination therapies, and MSC-derived extracellular vesicles.
What Are The Leading Drivers Of Growth In The Mesenchymal Stem Cells Market?
The increasing awareness of regenerative medicine is expected to boost the mesenchymal stem cells (MSC) market. This field focuses on the repair or regeneration of cells and tissues to restore impaired function. Key drivers of this growth include rising clinical trials, the growing prevalence of chronic conditions, and advances in personalized medicine. MSCs have the potential to treat a wide range of medical conditions due to their ability to differentiate into various cell types. According to the Alliance for Regenerative Medicine, there were 2,760 therapeutic developers worldwide in Q1 2023, a 101% increase from the previous year, fueling the growth of the MSC market.
How Are The Segments Defined Within The Global Mesenchymal Stem Cells Market?
The mesenchymal stem cells market covered in this report is segmented –
1) By Type: Autologous, Allogeneic
2) By Product Type: Cells And Cell Lines, Kits, Media And Reagents, Other Product Types
3) By Workflow Type: Cell Sourcing And Isolation, Culture And Cryopreservation, Differentiation, Characterization
4) By Indication: Bone And Cartilage Repair, Cardiovascular Diseases, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Other Indications
5) By Application: Disease Modeling, Drug Development And Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Other Applications
Subsegments:
1) By Autologous: Bone Marrow-Derived, Adipose Tissue-Derived, Cord Blood-Derived, Peripheral Blood-Derived
2) By Allogeneic: Bone Marrow-Derived, Umbilical Cord-Derived, Placental-Derived, Induced Pluripotent Stem Cells (iPSCs) Derived, Wharton's Jelly-Derived
Pre-Book The Mesenchymal Stem Cells Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Mesenchymal Stem Cells Market?
Leading firms in the mesenchymal stem cells (MSCs) market are leveraging novel technologies like GMP-compliant isolation to fortify their market standing. The term GMP (Good Manufacturing Practice)-compliant isolation indicates the cell isolation process, of cells like mesenchymal stem cells (MSCs), as per GMP rules for maintaining regular production and control of product quality. For example, PromoCell, a biotech company from Germany, in July 2023, revealed the introduction of PromoExQ MSC Growth Medium XF. This serum- and xeno-free medium is crafted for the enlargement of human mesenchymal stem cells (MSCs) in a GMP-regulated setting. Made to the uppermost quality standards, this medium has received certification from the EXCiPACT GMP certification program and guarantees the steady growth and maintenance of MSCs from diverse sources like bone marrow, the umbilical cord matrix, and adipose tissue.
Who Are the Key Players In The Mesenchymal Stem Cells Market?
Major companies operating in the mesenchymal stem cells market are:
• Thermo Fischer Scientific Inc.
• Danaher Corporation
• Merck KgaA
• Becton
• Dickinson
• and Company
• Fujifilm Holdings Corporation
• Corning Inc.
• Daiichi Sankyo
• Lonza Group
• Terumo Corporation
• Sartorius AG
• Getinge AB
• Bio-Rad Laboratories
• Eppendorf AG
• Bio-Techne Corporation
• STEMCELL Technologies Inc.
• Miltenyi Biotec GmBH
• Takara Bio Group
• Organogenesis Holdings Inc.
• Vericel Corporation
• HiMedia Laboratories
• PromoCell GmbH
• CellGenix GmBH
• Anterogen Co. Ltd.
• Pluristem Therapeutics Inc.
• American Cryostem Corporation
What Is The Most Dominant Region In The Mesenchymal Stem Cells Market?
North America was the largest region in the mesenchymal stem cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mesenchymal stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
